Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment

ClinicalTrials.gov ID: NCT00002334

Public ClinicalTrials.gov record NCT00002334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 7:27 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-Blind, Phase III, Parallel Study of Zidovudine (AZT) Alone Versus AZT Plus Zalcitabine (Dideoxycytidine; ddC) Versus AZT Plus Saquinavir Mesylate (Ro 31-8959 ; HIV Proteinase Inhibitor) Versus AZT Plus ddC Plus Ro 31-8959 in Previously Untreated or Minimally Pretreated HIV-Infected Patients With CD4 Lymphocyte Counts From 50 to <= 350 Cells/mm3

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare, in zidovudine (AZT)-naive patients, the safety, tolerance, and efficacy of saquinavir mesylate (Ro 31-8959) alone versus AZT alone versus AZT in combination with Ro 31-8959, zalcitabine (ddC), or both. To compare various disease markers among the different regimens.

Study identification

NCT ID
NCT00002334
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
3,000 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 24, 2005

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016 —
UCD Med Ctr Sacramento California 95817 —
Davies Med Ctr San Francisco California 94114 —
Mount Zion Med Ctr / UCSF San Francisco California 94115 —
Pacific Oaks Med Group Sherman Oaks California 91403 —
Sunnyvale Med Clinic Sunnyvale California 94086 —
Novum Inc Washington D.C. District of Columbia 20037 —
Howard Univ Washington D.C. District of Columbia 20060 —
Miami Veterans Administration Med Ctr Miami Florida 33125 —
Univ of Miami School of Medicine Miami Florida 331361013 —
Cook County Hosp Chicago Illinois 60612 —
Rush Presbyterian - Saint Luke's Med Ctr Chicago Illinois 60612 —
Tulane Univ Med School New Orleans Louisiana 701122699 —
Massachusetts Gen Hosp Boston Massachusetts 02114 —
HIV Wellness Ctr / Univ Med Ctr Las Vegas Nevada 89102 —
Beth Israel Med Ctr New York New York 10003 —
Harkness Pavilion New York New York 10032 —
Univ Hosp of Cleveland / Case Western Reserve Univ Cleveland Ohio 44106 —
Univ of Oklahoma Health Science / Pharmacy Practice Oklahoma City Oklahoma 73117 —
Novum Inc Pittsburgh Pennsylvania 152063817 —
Respiratory Associates Corpus Christi Texas 78404 —
N Texas Ctr for AIDS & Clin Rsch Dallas Texas 75219 —
Univ TX Galveston Med Branch Galveston Texas 775550882 —
Thomas Street Clinic / Baylor College of Medicine Houston Texas 77009 —
Univ of Washington Seattle Washington 981224379 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002334 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →